Homepage

Read about the COVID-19 Oxford Vaccine Trial.

A girl wearing a mask with "welcome back to school" written on it.

There is now clear data on Covid-19 and children: it should be safe to reopen English schools

In an opinion piece for The Guardian, Professor Matthew Snape discusses the initial results of his team's antibody study in the context of coronavirus risk to school children.

Ebola vaccine approved for use by the European Commission

The European Commission has granted Marketing Authorisation to Janssen for a new Ebola vaccine, developed in partnership with the University of Oxford.

Typhoid vaccine project wins Vice-Chancellor award

Congratulations to Professor Andrew Pollard who is the Winner of the Policy Engagement category in the Vice-Chancellor Innovation Awards 2020 for his work on Global policy on typhoid vaccines through research at Oxford!

Trial participant having a blood sample taken.

New study reveals Oxford coronavirus vaccine produces strong immune response

A team of scientists at Oxford Vaccine Group (Department of Paediatrics) and Oxford University’s Jenner Institute has taken the next step towards the discovery of a safe, effective and accessible vaccine against coronavirus.

OVG study sheds light on coronavirus immunity in children

First results of the What’s the STORY (Serum Testing Of Representative Youngsters) trial indicate higher resilience of children to COVID-19 compared to other respiratory illnesses.

Trial of Oxford COVID-19 vaccine starts in Brazil

Volunteers have begun taking part in Latin America’s first clinical trial for a vaccine against COVID-19.

Coronavirus: the road to vaccine roll-out is always bumpy, as 20th-century pandemics show

Public trust is key to a successful immunisation programme, writes Samantha Vanderslott in a piece for The Conversation.

Take part in a clinical trial – see a list of all the trials we are currently recruiting to.

Vaccine Knowledge

The Vaccine Knowledge Project aims to be a source of independent information about vaccines and infectious diseases.

See more

Research

Vaccines are a key component of global health policy and are essential in the defence of the health of young children. Our research focuses on the development and evaluation of new and improved vaccines.

Explore

Events and Training

We are committed to providing high quality education and training, together with research updates for medical professionals and all those involved in the area of vaccines and paediatric and adult infectious diseases.

Learn

Get involved

There are a number of ways in which you can get involved in our research, inform our research and find out more about our work. To find out more about any of these options, follow the link below.

Participate

Upcoming events

Online Introduction to Immunisation Training - 3 November 2020

Tuesday, 03 November 2020, 9.30am to 2.30pm

This training is for general practice nurses and other health professionals who are new to the role of administering and promoting and / or advising about vaccines.

Latest publications

Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the United Kingdom – a cross-sectional, observational survey.
Journal article

MAIDEN M. et al, (2020), The Lancet Infectious Diseases
Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection model.
Journal article

Gibani MM. et al, (2020), PLoS Negl Trop Dis, 14
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN®-Filo Ebola vaccine regimen: a phase 2 randomised clinical study in Europe (EBOVAC2)
Journal article

POLLARD A., (2020), Lancet Infectious Diseases
A Bayesian approach for estimating typhoid fever incidence from large-scale facility-based passive surveillance data
Journal article

Phillips MT. et al, (2020)
Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review.
Journal article

Sudbury EL. et al, (2020), J Infect

How does herd immunity work?

‘Herd immunity’ or 'herd protection' gives protection to vulnerable people such as newborn babies, elderly people and those who are too sick to be vaccinated.

Value of Vaccines campaign

We recently worked with Mediaplanet on the 2019 Health Awareness: Value of Vaccines campaign. The campaign features exclusive content from key thought leaders and industry voices about the critical importance of full immunisation throughout life.

Take a look!